ATS Corporation (ATS) FinancialsATSFinancialATS Corporation

ATS Corporation (ATS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Life sciences, accounting for 49.9% of total sales, equivalent to CAD 345.93M. Other significant revenue streams include Consumer products and Food & beverage. Understanding this composition is critical for investors evaluating how ATS navigates market cycles within the Industrial Machinery & Equipment industry.

Evaluating the bottom line, ATS Corporation maintains a gross margin of 27.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.16%, while the net margin is -0.04%. These profitability ratios, combined with a Return on Equity (ROE) of 2.69%, provide a clear picture of how effectively ATS converts its operational activities into shareholder value.

In the context of the broader market, ATS competes directly with industry leaders such as NWL and WOR. With a market capitalization of $1.99B, it holds a significant position in the sector. When comparing efficiency, ATS's gross margin of 27.38% stands against NWL's 40.77% and WOR's 27.43%. Such benchmarking helps identify whether ATS Corporation is trading at a premium or discount relative to its financial performance.

ATS Corp has shown fluctuating financial performance with a recent revenue of CAD 693.7 million for Q1 2027, which is a 5.2% year-over-year decrease. The gross margin has also declined to 25.82% in Q4 2026, indicating pressure on profitability.